# Study of Sorafenib Maintenance in Patients With ED-SCLC After Response to Induction Chemotherapy

> **NCT01159327** · PHASE2 · TERMINATED · sponsor: **National Cancer Center, Korea** · enrollment: 13 (actual)

## Conditions studied

- Small Cell Lung Cancer

## Interventions

- **DRUG:** Sorafenib

## Key facts

- **NCT ID:** NCT01159327
- **Lead sponsor:** National Cancer Center, Korea
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-12
- **Primary completion:** 2013-04
- **Final completion:** 2013-06
- **Target enrollment:** 13 (ACTUAL)
- **Why stopped:** low enrolling participants
- **Last updated:** 2015-11-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01159327

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01159327, "Study of Sorafenib Maintenance in Patients With ED-SCLC After Response to Induction Chemotherapy". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01159327. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*